Stem cell separation: a bottleneck in stem cell therapy

Biotechnology Journal
Kornelia SchrieblAlois Jungbauer

Abstract

The substantial progress in embryonic stem cell (ESC) research could lead to new possibilities in the treatment of various diseases. Currently, applications of ESC for cell therapy are impeded by the presence of potentially teratoma-forming undifferentiated ESC. Thus, a selective and quantitative removal of undifferentiated ESC from a pool of differentiated and undifferentiated cells is essential before cell therapy. We evaluated the highly selective magnetic activated cell sorting (MACS) method for the quantitative removal of undifferentiated ESC. We found that the clearance rates for undifferentiated ESC decreased with decreasing amount of undifferentiated ESC in the cell pool. Using a simplified model calculation we could predict that, assuming an initial purity of 60%, an estimated 31 steps are required to achieve less than 10(-1) cell per 10(9) cells. Thus, a log clearance rate of 10, which would be necessary for a therapeutically application, is hard to achieve. Our work clearly indicates that the current MACS technology is insufficient to meet the purification needs for cell therapy.

References

Nov 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·D Solter, B B Knowles
Jun 27, 1990·Journal of Chromatography·P GirotE Boschetti
Aug 3, 1984·Journal of Chromatography·H A Chase
Apr 1, 1980·The Biochemical Journal·D W Mason, A F Williams
Aug 1, 1995·Developmental Biology·M Pesce, M De Felici
Jul 22, 1998·Journal of Immunological Methods·B A HarrisonE Altman
Mar 6, 1999·Journal of Chromatography. B, Biomedical Sciences and Applications·I Safarík, M Safaríková
Jan 11, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M MüllerW M Franz
Sep 21, 2002·Circulation Research·Chunhui XuMelissa K Carpenter
May 14, 2003·Stem Cells·Maya SchuldinerNissim Benvenisty
Sep 19, 2003·Tissue Engineering·P W ZandstraL J Field
Dec 9, 2003·Journal of Immunological Methods·Ashok KumarBo Mattiasson
Mar 11, 2004·Journal of Neurochemistry·Tibor HarkanyPatrik Ernfors
Jun 19, 2004·Cytotherapy·B LawrenzS Esser
Sep 25, 2004·Journal of Cellular Physiology·Hanjoon M SongMichael T Longaker

❮ Previous
Next ❯

Citations

Dec 29, 2011·ACS Chemical Biology·Joseph R KlimLaura L Kiessling
Aug 20, 2011·British Medical Bulletin·Elizabeth RatcliffeDavid J Williams
May 8, 2014·Tissue Engineering. Part C, Methods·Peter D MitchellRobert J Thomas
Aug 14, 2012·Biotechnology and Bioengineering·Maria Margarida DiogoJoaquim M S Cabral
Apr 9, 2015·Biotechnology Journal·Gonçalo M C RodriguesJoaquim M S Cabral
May 22, 2013·Critical Reviews in Biotechnology·Mirna González-González, Marco Rito-Palomares
Jan 1, 2011·Annual Review of Chemical and Biomolecular Engineering·François BerthiaumeMartin L Yarmush
Jan 10, 2020·Lab on a Chip·Ewa GuzniczakHelen Bridle
Dec 30, 2014·Expert Review of Medical Devices·Martin ReinhardtShibashish Giri
May 23, 2020·Acta Biomaterialia·Kaitlyn BaconStefano Menegatti
Mar 19, 2021·Critical Reviews in Biotechnology·Alonso Ornelas-GonzálezMarco Rito-Palomares
Aug 15, 2021·Cell and Tissue Research·Deming JiangPing Wang
May 25, 2012·Journal of Chromatography. a·Federico Ruiz-RuizMarco Rito-Palomares

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.